D000806Chemicals & DrugsD27.505.519.389.745.08516260.976489Angiotensin-Converting Enzyme InhibitorsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1.051170.032533716research area of0.8528090.053523533subject area forAdult Health and Gerontological NursingOtolaryngologySamerAl-KhudariSamer Al-Khudari349146Al-Khudari, SamerAssistant ProfessorFarahnakAssadiFarahnak Assadi349157Assadi, FarahnakAssociate ProfessorPhilipLiebsonPhilip R. Liebson349403Liebson, PhilipProfessorJohnSombergJohn Somberg349673Somberg, JohnProfessorAnnabelleVolgmanAnnabelle Volgman349709Volgman, AnnabelleProfessor31960742Brown SA, Okwuosa TM, Barac A, Volgman ASJournal of the American Heart AssociationThe Role of Angiotensin-Converting Enzyme Inhibitors and ?-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. J Am Heart Assoc. 2020 01 21; 9(2):e015327.J Am Heart Assoc2020-01-21T00:00:002020The Role of Angiotensin-Converting Enzyme Inhibitors and ?-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients.6Assistant Professor5Associate Professor4Professor22020885Al-Khudari S, Loochtan MJ, Peterson E, Yaremchuk KLThe LaryngoscopeManagement of angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope. 2011 Nov; 121(11):2327-34.Laryngoscope2011-11-01T00:00:002011Management of angiotensin-converting enzyme inhibitor-induced angioedema.19682819Miceli A, Capoun R, Fino C, Narayan P, Bryan AJ, Angelini GD, Caputo MJournal of the American College of CardiologyEffects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2009 Nov 03; 54(19):1778-84.J Am Coll Cardiol2009-08-13T00:00:002009Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.Internal MedicineRush University, College of NursingRush University, Rush Medical College34889102Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SSJournal of the American Heart AssociationAngiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021 12 21; 10(24):e023535.J Am Heart Assoc2021-12-10T00:00:002021Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.18930568Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang HAmerican journal of kidney diseases : the official journal of the National Kidney FoundationCombination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis. 2009 Jan; 53(1):26-32.Am J Kidney Dis2008-10-19T00:00:002008Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorInternal Medicine, Division of Cardiologytrue1Associate ProfessorAssociate Professor